Brian A. Kahan, Esquire, on behalf of Lato Drug Company and Robert Fishman, RPH; The Notice of Petition for Declaratory Statement was published in Volume 41, No. 44, of the March 5, 2015, Florida Administrative Register. The Petitioners sought a ...

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-27.700Definition of Compounding

NOTICE IS HEREBY GIVEN that the Board of Pharmacy has issued an order disposing of the petition for declaratory statement filed by Brian A. Kahan, Esquire, on behalf of Lato Drug Company and Robert Fishman, RPH on February 3, 2015. The following is a summary of the agency’s disposition of the petition:

The Notice of Petition for Declaratory Statement was published in Volume 41, No. 44, of the March 5, 2015, Florida Administrative Register. The Petitioners sought a Declaratory Statement from the Board with regard to Section 465.185(1), F.S. and Rule 64B16-27.700, F.A.C., that the petitioners’ contemplated business arrangement for compounding medications for veterinary use, as outlined in the petition, would not subject Petitioners to discipline under the cited statute and rule. The Board of Pharmacy considered the Petition at a duly-noticed public meeting held on April 7, 2015, in Tampa, Florida. After discussion regarding the merits of the Petition, Petitioner moved to withdraw the Petition for Declaratory Statement. The Board’s Order, filed on April 28, 2015, granted the request to withdraw the Petition for Declaratory Statement and dismiss the cause.

A copy of the Order Disposing of the Petition for Declaratory Statement may be obtained by contacting: Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254 or by email: [e-mail].